Advertisement
Screener

Biostar Pharmaceuticals, Inc. Revenue

Biostar Pharmaceuticals, Inc. Revenue

Biostar Pharmaceuticals, Inc. reported Revenue of $0 for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-11-20.

Discontinued › Income Statement

us-gaap:SalesRevenueNet · last filed 2017-11-20

  • Biostar Pharmaceuticals, Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $0.00, a 100.00% decline year-over-year.
  • Biostar Pharmaceuticals, Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $0.00, a 100.00% decline year-over-year.
  • Biostar Pharmaceuticals, Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $0.00, a 100.00% decline year-over-year.
  • Biostar Pharmaceuticals, Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2016-12-31 was $317.79K, a 82.71% decline year-over-year.
  • Biostar Pharmaceuticals, Inc. revenue, net (deprecated 2018-01-31) for fiscal 2016 was $2.38M, a 91.21% decline from fiscal 2015.
  • Biostar Pharmaceuticals, Inc. revenue, net (deprecated 2018-01-31) for fiscal 2015 was $27.13M, a 55.83% decline from fiscal 2014.
  • Biostar Pharmaceuticals, Inc. revenue, net (deprecated 2018-01-31) for fiscal 2014 was $61.42M, a 16.48% increase from fiscal 2013.
  • Biostar Pharmaceuticals, Inc. revenue, net (deprecated 2018-01-31) for fiscal 2013 was $52.73M, a 6.92% increase from fiscal 2012.
Period endRevenue, Net (Deprecated 2018-01-31) 3 monthRevenue, Net (Deprecated 2018-01-31) 6 monthRevenue, Net (Deprecated 2018-01-31) 9 monthRevenue, Net (Deprecated 2018-01-31) 12 month
2017-09-30$0.00
10-Q · filed 2017-11-20
$0.00
derived: sum of 2 quarters · filed 2017-11-20
$0.00
10-Q · filed 2017-11-20
$317.79K
derived: sum of 4 quarters · filed 2017-11-20
2017-06-30$0.00
10-Q · filed 2017-11-15
$0.00
10-Q · filed 2017-11-15
$317.79K
derived: sum of 3 quarters · filed 2017-11-15
$962.73K
derived: sum of 4 quarters · filed 2017-11-20
2017-03-31$0.00
10-Q · filed 2017-05-19
$317.79K
derived: sum of 2 quarters · filed 2017-05-19
$962.73K
derived: sum of 3 quarters · filed 2017-11-20
$1.58M
derived: sum of 4 quarters · filed 2017-11-20
2016-12-31$317.79K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-13
$962.73K
derived: sum of 2 quarters · filed 2017-11-20
$1.58M
derived: sum of 3 quarters · filed 2017-11-20
$2.38M
10-K · filed 2017-04-13
2016-09-30$644.93K
10-Q · filed 2017-11-20
$1.27M
derived: sum of 2 quarters · filed 2017-11-20
$2.07M
10-Q · filed 2017-11-20
$3.90M
derived: sum of 4 quarters · filed 2017-11-20
2016-06-30$620.14K
10-Q · filed 2017-11-15
$1.42M
10-Q · filed 2017-11-15
$3.26M
derived: sum of 3 quarters · filed 2017-11-15
$7.47M
derived: sum of 4 quarters · filed 2017-11-15
2016-03-31$801.63K
10-Q · filed 2017-05-19
$2.64M
derived: sum of 2 quarters · filed 2017-05-19
$6.85M
derived: sum of 3 quarters · filed 2017-05-19
$21.02M
derived: sum of 4 quarters · filed 2017-05-19
2015-12-31$1.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-13
$6.04M
derived: sum of 2 quarters · filed 2017-04-13
$20.22M
derived: sum of 3 quarters · filed 2017-04-13
$27.13M
10-K · filed 2017-04-13
2015-09-30$4.21M
10-Q · filed 2016-11-21
$18.38M
derived: sum of 2 quarters · filed 2016-11-21
$25.29M
10-Q · filed 2016-11-21
$39.68M
derived: sum of 4 quarters · filed 2016-11-21
2015-06-30$14.18M
10-Q · filed 2016-08-22
$21.08M
10-Q · filed 2016-08-22
$35.47M
derived: sum of 3 quarters · filed 2016-08-22
$50.12M
derived: sum of 4 quarters · filed 2016-08-22
2015-03-31$6.91M
10-Q · filed 2016-05-23
$21.29M
derived: sum of 2 quarters · filed 2016-05-23
$35.95M
derived: sum of 3 quarters · filed 2016-05-23
$55.14M
derived: sum of 4 quarters · filed 2016-05-23
2014-12-31$14.39M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-04-14
$29.04M
derived: sum of 2 quarters · filed 2016-04-14
$48.24M
derived: sum of 3 quarters · filed 2016-04-14
$61.42M
10-K · filed 2016-04-14
2014-09-30$14.65M
10-Q · filed 2015-11-23
$33.85M
derived: sum of 2 quarters · filed 2015-11-23
$47.03M
10-Q · filed 2015-11-23
$58.01M
derived: sum of 4 quarters · filed 2015-11-23
2014-06-30$19.20M
10-Q · filed 2015-08-19
$32.38M
10-Q · filed 2015-08-19
$43.36M
derived: sum of 3 quarters · filed 2015-08-19
$58.37M
derived: sum of 4 quarters · filed 2015-08-19
2014-03-31$13.18M
10-Q · filed 2015-05-15
$24.16M
derived: sum of 2 quarters · filed 2015-05-15
$39.17M
derived: sum of 3 quarters · filed 2015-05-15
$53.82M
derived: sum of 4 quarters · filed 2015-05-15
2013-12-31$10.98M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-15
$25.99M
derived: sum of 2 quarters · filed 2015-04-15
$40.64M
derived: sum of 3 quarters · filed 2015-04-15
$52.73M
10-K · filed 2015-04-15
2013-09-30$15.01M
10-Q · filed 2014-11-14
$29.66M
derived: sum of 2 quarters · filed 2014-11-14
$41.75M
10-Q · filed 2014-11-14
$57.04M
derived: sum of 4 quarters · filed 2014-11-14
2013-06-30$14.65M
10-Q · filed 2014-08-14
$26.74M
10-Q · filed 2014-08-14
$42.03M
derived: sum of 3 quarters · filed 2014-08-14
$52.00M
derived: sum of 4 quarters · filed 2014-08-14
2013-03-31$12.09M
10-Q · filed 2014-05-15
$27.38M
derived: sum of 2 quarters · filed 2014-05-15
$37.35M
derived: sum of 3 quarters · filed 2014-05-15
$45.51M
derived: sum of 4 quarters · filed 2014-05-15
2012-12-31$15.29M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31
$25.26M
derived: sum of 2 quarters · filed 2014-03-31
$33.42M
derived: sum of 3 quarters · filed 2014-03-31
$49.32M
10-K · filed 2014-03-31
2012-09-30$9.97M
10-Q · filed 2013-11-14
$18.13M
derived: sum of 2 quarters · filed 2013-11-14
$34.03M
10-Q · filed 2013-11-14
$60.01M
derived: sum of 4 quarters · filed 2013-11-14
2012-06-30$8.16M
10-Q · filed 2013-08-19
$24.06M
10-Q · filed 2013-08-19
$50.04M
derived: sum of 3 quarters · filed 2013-08-19
$74.82M
derived: sum of 4 quarters · filed 2013-08-19
2012-03-31$15.90M
10-Q · filed 2013-05-15
$41.88M
derived: sum of 2 quarters · filed 2013-05-15
$66.66M
derived: sum of 3 quarters · filed 2013-05-15
$92.58M
derived: sum of 4 quarters · filed 2013-05-15
2011-12-31$25.99M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-04-15
$50.76M
derived: sum of 2 quarters · filed 2013-04-15
$76.68M
derived: sum of 3 quarters · filed 2013-04-15
$91.97M
10-K · filed 2013-04-15
2011-09-30$24.78M
10-Q · filed 2012-11-19
$50.69M
derived: sum of 2 quarters · filed 2012-11-19
$65.98M
10-Q · filed 2012-11-19
$94.26M
derived: sum of 4 quarters · filed 2012-11-19
2011-06-30$25.91M
10-Q · filed 2012-08-14
$41.20M
10-Q · filed 2012-08-14
$69.48M
derived: sum of 3 quarters · filed 2012-08-14
$89.66M
derived: sum of 4 quarters · filed 2012-08-14
2011-03-31$15.29M
10-Q · filed 2012-05-15
$43.57M
derived: sum of 2 quarters · filed 2012-05-15
$63.74M
derived: sum of 3 quarters · filed 2012-05-15
$83.14M
derived: sum of 4 quarters · filed 2012-05-15
2010-12-31$28.28M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-27
$48.46M
derived: sum of 2 quarters · filed 2012-03-27
$67.85M
derived: sum of 3 quarters · filed 2012-03-27
$80.21M
10-K · filed 2012-03-27
2010-09-30$20.18M
10-Q · filed 2011-11-14
$39.57M
derived: sum of 2 quarters · filed 2011-11-14
$51.94M
10-Q · filed 2011-11-14
2010-06-30$19.40M
10-Q · filed 2011-08-15
$31.76M
10-Q · filed 2011-08-15